- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 5, 2025 | 18.7M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 18.7M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 13.87M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 1.35M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 1.33M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $183K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$31.31M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$12.82M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $34.61M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $0 |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $42.39M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $1.64M |
| Cash And Equivalents restated | Q3 2025 · Sep 30, 2024 | $1.91M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $41.87M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $53.12M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $63.87M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$96.62M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | −$89.38M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | −$51.53M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | −$47.54M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | −$45.02M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $6.07M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $24.7M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $39.31M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $56.78M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $78.18M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $2.61M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $81.18M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $6.16M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.64 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$2.41 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$28.16 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$35.44 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.64 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$2.41 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$28.16 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$35.44 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $3.62M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $11.76M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.83M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $3.41M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $9.13M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $23.6M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $36.02M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $41.19M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$11.89M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$33.44M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$11.35M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$10.2M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$38.08M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$47.14M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$5.65M |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$3.41M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$12.74M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$35.35M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$37.85M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$44.6M |